Post-Brexit point-based immigration system will affect the UK’s healthcare system: Poll
Verdict conducted a poll to analyse the impact of the post-Brexit points-based immigration system on the UK’s healthcare system.
Verdict conducted a poll to analyse the impact of the post-Brexit points-based immigration system on the UK’s healthcare system.
Cell and gene therapy is a rapidly evolving experimental space that saw almost £20bn in...
US industry association the Pharmaceutical Research and Manufacturers of America (PhRMA) has released a series of policies it says will...
Oxford University researchers have found that a cheap asthma drug can help speed up recovery for people at home with...
Sanofi and drug discovery company C4X Discovery (C4XD) have entered an exclusive worldwide licensing agreement worth up to €414m for...
In mid-March, a number of European countries paused their rollout of the AstraZeneca (AZ) Covid-19 vaccine after reports of blood clots in a small number of those who received the…
Moderna’s Covid-19 vaccine rollout has begun in the UK, where patients in Wales have been the first to receive a dose. Supplies arrived in Wales on Tuesday, with 5,000 doses…
The European Commission has approved Novartis’s Kesimpta (ofatumumab) for the treatment of relapsing forms of multiple sclerosis (RMS) in adults with active disease defined by clinical or imaging features. Kesimpta…
The European Commission has granted marketing authorisation to PTC Therapeutics’ Evrysdi (risdiplam) for the at-home treatment of spinal muscular atrophy (SMA) in patients aged two months and older. The drug,…
SalioGen Therapeutics has raised $20m to support preclinical validation of its platform, Exact DNA Integration Technology (EDIT), for developing non-viral vector gene therapies using the enzyme saliogase, which SalioGen has…
Pfizer/BioNTech’s Comirnaty (tozinameran) is forecast to have greater peak sales than the world’s largest blockbuster, Abbvie’s rheumatoid arthritis drug Humira (adalimumab), by its second year of being on the market.…